Skip to main navigation Skip to search Skip to main content

Reply: SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival

J. S. Thompson Coon, Z. Liu, M. Hoyle, G. Rogers, C. Green, T. Moxham, K. Welch, K. Stein

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)234-235
Number of pages2
JournalBritish Journal of Cancer
Volume102
Issue number1
DOIs
Publication statusPublished - Jan 2010
Externally publishedYes

Cite this